Advanced Biomedical Technologies, Inc.
ABMT · OTC
7/31/2022 | 4/30/2022 | 1/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,241 | $3,533 | $6,354 | $4,942 |
| - Cash | $6 | $29 | $8 | $37 |
| + Debt | $7,095 | $7,050 | $7,064 | $6,889 |
| Enterprise Value | $11,330 | $10,554 | $13,410 | $11,795 |
| Revenue | -$5 | -$0 | $281 | $124 |
| % Growth | -4,742.2% | -100% | 127.6% | – |
| Gross Profit | -$7 | -$7 | $241 | $91 |
| % Margin | 147.6% | 6,584.3% | 85.6% | 73.4% |
| EBITDA | -$104 | -$100 | $148 | -$81 |
| % Margin | 2,105% | 97,856.9% | 52.4% | -65.8% |
| Net Income | -$190 | -$190 | $58 | -$170 |
| % Margin | 3,842.6% | 186,752.9% | 20.6% | -137.1% |
| EPS Diluted | -0.003 | -0.003 | 0.001 | -0.002 |
| % Growth | 0% | -437.5% | 133.3% | – |
| Operating Cash Flow | -$170 | -$197 | -$162 | -$97 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$170 | -$197 | -$162 | -$97 |